Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 17, 2022

SELL
$38.88 - $45.31 $645,330 - $752,055
-16,598 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$38.79 - $43.16 $643,836 - $716,369
16,598 New
16,598 $634,000
Q2 2021

Sep 17, 2021

SELL
$36.52 - $41.46 $399,711 - $453,779
-10,945 Closed
0 $0
Q1 2021

May 19, 2021

SELL
$34.27 - $40.01 $545,646 - $637,039
-15,922 Reduced 59.26%
10,945 $391,000
Q4 2020

Feb 24, 2021

SELL
$34.07 - $39.94 $250,210 - $293,319
-7,344 Reduced 21.47%
26,867 $989,000
Q3 2020

Dec 11, 2020

BUY
$38.11 - $42.99 $1.3 Million - $1.47 Million
34,211 New
34,211 $1.29 Million
Q2 2020

Aug 07, 2020

SELL
$37.87 - $43.58 $559,756 - $644,155
-14,781 Closed
0 $0
Q4 2019

Feb 04, 2020

BUY
$42.0 - $48.25 $620,802 - $713,183
14,781 New
14,781 $694,000
Q3 2019

Nov 20, 2019

SELL
$40.46 - $43.52 $228,396 - $245,670
-5,645 Closed
0 $0
Q2 2019

Aug 13, 2019

SELL
$39.4 - $42.7 $304,877 - $330,412
-7,738 Reduced 57.82%
5,645 $226,000
Q1 2019

Apr 12, 2019

SELL
$38.57 - $42.69 $105,681 - $116,970
-2,740 Reduced 16.99%
13,383 $559,000
Q4 2018

Jan 16, 2019

SELL
$37.8 - $42.69 $382,044 - $431,467
-10,107 Reduced 38.53%
16,123 $616,000
Q3 2018

Nov 13, 2018

BUY
$39.75 - $42.69 $1.04 Million - $1.12 Million
26,230 New
26,230 $1.05 Million
Q2 2018

Jul 30, 2018

SELL
$39.61 - $42.76 $1.45 Million - $1.56 Million
-36,572 Closed
0 $0
Q2 2018

Jul 30, 2018

BUY
$39.61 - $42.76 $791,170 - $854,088
19,974 Added 120.34%
36,572 $1.47 Million
Q1 2018

May 14, 2018

SELL
$36.18 - $40.15 $4.01 Million - $4.45 Million
-110,739 Reduced 86.97%
16,598 $648,000
Q4 2017

Feb 09, 2018

BUY
$35.34 - $41.9 $4.5 Million - $5.34 Million
127,337
127,337 $4.52 Million

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.